Literature DB >> 10657494

Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain.

J A Chowen1, F R de Fonseca, E Alvarez, M Navarro, L M García-Segura, E Blázquez.   

Abstract

Glucagon-like peptide-1 (GLP-1)(7-36) amide, a member of the glucagon and related peptides family, and its receptor have an anatomically specific expression in the brain. Furthermore, the GLP-1 receptor is expressed in both neurons and glia. Because after a penetrating injury a large population of astrocytes become activated and augment their expression of numerous substances, we have used in situ hybridization to determine whether the expression of the GLP-1 receptor increases in response to a penetrating injury. We have found that GLP-1 receptor expression increases dramatically along the border of the injury. Furthermore, this expression can be colocalized to glial fibrillary acidic protein (GFAP) and non-GFAP mRNA containing cells, suggesting that at least part of this increase is due to an increase in GLP-1 receptor expression in glial cells. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10657494     DOI: 10.1054/npep.1999.0757

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  28 in total

1.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

Review 2.  Glucagon-like peptide 1 (GLP-1) and metabolic diseases.

Authors:  C M Rotella; L Pala; E Mannucci
Journal:  J Endocrinol Invest       Date:  2005-09       Impact factor: 4.256

3.  Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease.

Authors:  Ghada A Badawi; Mai A Abd El Fattah; Hala F Zaki; Moushira I El Sayed
Journal:  Inflammopharmacology       Date:  2017-03-04       Impact factor: 4.473

Review 4.  Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.

Authors:  Isidro Salcedo; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

5.  Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.

Authors:  Chi-Ho Lee; Se Jin Jeon; Kyu Suk Cho; Eunjung Moon; Arjun Sapkota; Hee Sook Jun; Jong Hoon Ryu; Ji Woong Choi
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

Review 6.  Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.

Authors:  Alexander Harkavyi; Peter S Whitton
Journal:  Br J Pharmacol       Date:  2010-01-29       Impact factor: 8.739

7.  GLP-1R activation for the treatment of stroke: updating and future perspectives.

Authors:  Vladimer Darsalia; David Nathanson; Thomas Nyström; Thomas Klein; Åke Sjöholm; Cesare Patrone
Journal:  Rev Endocr Metab Disord       Date:  2014-09       Impact factor: 6.514

8.  Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury.

Authors:  Nigel H Greig; David Tweedie; Lital Rachmany; Yazhou Li; Vardit Rubovitch; Shaul Schreiber; Yung-Hsiao Chiang; Barry J Hoffer; Jonathan Miller; Debomoy K Lahiri; Kumar Sambamurti; Robert E Becker; Chaim G Pick
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

9.  Association between GLP-1 receptor gene polymorphisms with reward learning, anhedonia and depression diagnosis.

Authors:  Hale Yapici-Eser; Vivek Appadurai; Candan Yasemin Eren; Dilek Yazici; Chia-Yen Chen; Dost Öngür; Diego A Pizzagalli; Thomas Werge; Mei-Hua Hall
Journal:  Acta Neuropsychiatr       Date:  2020-03-26       Impact factor: 3.403

10.  Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance.

Authors:  David J Reiner; Elizabeth G Mietlicki-Baase; Lauren E McGrath; Derek J Zimmer; Kendra K Bence; Gregory L Sousa; Vaibhav R Konanur; Joanna Krawczyk; David H Burk; Scott E Kanoski; Gerlinda E Hermann; Richard C Rogers; Matthew R Hayes
Journal:  J Neurosci       Date:  2016-03-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.